Cipla trades higher on the BSE

16 Nov 2018 Evaluate

Cipla is currently trading at Rs. 530.60, up by 11.60 points or 2.24% from its previous closing of Rs. 519.00 on the BSE.

The scrip opened at Rs. 522.00 and has touched a high and low of Rs. 532.30 and Rs. 522.00 respectively. So far 92478 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 508.10 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 541.80 and Rs. 515.00 respectively. The current market cap of the company is Rs. 42569.65 crore.

The promoters holding in the company stood at 36.74%, while Institutions and Non-Institutions held 39.45% and 23.81% respectively.

InvaGen Pharmaceuticals Inc., a subsidiary of the leading global pharmaceutical company Cipla, has entered into definitive agreements with two closing stages for a proposed acquisition of Avenue Therapeutics, Inc., a Fortress Biotech company focused on the development and commercialization of intravenous (IV) Tramadol.

At the first stage closing, InvaGen or its affiliates will acquire, through the issuance by Avenue of new shares, shares representing a 33.3% stake in Avenue’s capital stock on a fully diluted basis for $35 million.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1466.15 5.55 (0.38%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×